Full Press Release Details
New Survey Of U.S. Adults With Diabetes Reveals Less Than Half Understand Their Risk For Vision Loss.
REGN
New Survey Of U.S. Adults With Diabetes Reveals Less Than Half Understand Their Risk For Vision Loss
Key Takeaway: New Survey Of U.S. Adults With Diabetes Reveals Less Than Half Understand Their Risk For Vision Loss
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+42%
120-day peak, hindsight
Typical move
2.7%
average across 15 past catalysts
Lead asset
REGN7508
Phase 3 · Venous Thromboembolism